Extended-release Buprenorphine as a Novel Low-dose Induction Strategy

NCT06441604 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Extended-release Buprenorphine

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]